Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China · Delayed Price · Currency is CNY 31.68
+0.08 (0.25%)
At close: Aug 14, 2026
SHA:688273 Revenue
Nanjing Medlander Medical Technology had revenue of 99.20M CNY in the quarter ending March 31, 2026, a decrease of -16.13%. This brings the company's revenue in the last twelve months to 412.52M, down -5.92% year-over-year. In the year 2025, Nanjing Medlander Medical Technology had annual revenue of 431.59M with 1.66% growth.
Revenue (ttm)
412.52M
Revenue Growth
-5.92%
P/S Ratio
7.51
Revenue / Employee
n/a
Employees
550
Market Cap
3.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 431.59M | 7.04M | 1.66% |
| Dec 31, 2024 | 424.55M | 83.72M | 24.57% |
| Dec 31, 2023 | 340.82M | -36.06M | -9.57% |
| Dec 31, 2022 | 376.89M | 35.25M | 10.32% |
| Dec 31, 2021 | 341.64M | 5.12M | 1.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.65B |
| Guangdong Transtek Medical Electronics | 996.64M |
| Ningbo David Medical Device | 575.66M |
| Chison Medical Technologies | 435.38M |
| Jiangsu Canopus Wisdom Medical Technology | 399.78M |
| Shanghai General Healthy Information and Technology | 344.43M |
| Kontour (Xi'an) Medical Technology | 342.27M |
| Beijing Leadman Biochemistry | 317.86M |